Latest

Christophe Arfan, Associate and UPC Representative (Osborne Clarke (France))

Comments on EPO decisions G 1/23 and G 1/24 – Part One

September 18, 2025

In less than 15 days, the Enlarged Board of Appeals (“EBA”) handed down two major decisions in relation to patent validity: (i) one relating to claim construction when assessing the patentability of…

Articles

Enjoy new articles covering various topics every day. If you would like to join our authors and gain recognition in a legal world contact Editorial Guidelines.

Enrico Bonadio (City St. George’s, University of London) , Rebekka Porath (IP Fellow, Innovators Network Foundation)

Restoring Balance in SEPs Governance - Next Steps for the EU After the Regulation's Withdrawal

September 15, 2025

The withdrawal of the European Commission’s Standard Essential Patents (SEPs) Regulation proposal earlier this year has left a significant void in EU intellectual property policy. This decision was…

Rob Rodrigues (RNA Law)

Lawsuit publicity & IP Litigation in Brazil

September 15, 2025

Co-authored by Karlo TinocoBrazilian Court actions are, as a rule, public, with case files accessible to anyone regardless of the reason. This principle of publicity, anchored in the Constitution, is…

John Collins (Clayton Utz) , Kent Teague , Emina Besirevic (Clayton Utz)

Australia patents update: Federal Court revisits best method knowledge requirement for divisional patents

September 11, 2025

The Federal Court’s decision in The NOCO Company v Brown and Watson International Pty Ltd [2025] FCA 887 has provided a welcome update on the relevant date for assessing the best method knowledge…

Rob Rodrigues (RNA Law)

SHARED OWNERSHIP OF PATENTS AND THE CHALLENGES OF CO-OWNERSHIP UNDER BRAZILIAN LAW

September 7, 2025

In an increasingly collaboration-driven innovation landscape, it is common for inventions to arise from joint efforts among universities, companies, and research centers. This reality calls for…

Jiří Slavík (European Patent Attorney | Director IP at Adalvo)

Substantiating Infringement (or Risk Thereof) at the UPC: Divide & Conquer or One To Rule Them All?

September 4, 2025

Traditionally, patents are territorial rights: their effects are limited to the territory in which they take effect, and therefore any infringing acts are necessarily localised in that territory…

Claire Phipps-Jones (Bristows) , Florence Plisner (Bristows)

Strategic missteps and legal lessons: how Alexion’s eculizumab patent fared in the UK and UPC

September 2, 2025

Readers will likely be aware of the cross-jurisdictional litigation considering infringement by Samsung Bioepis / Amgen’s biosimilar eculizumab products of Alexion’s patent, EP 3 167 888 B1 (“EP 888”…